Trump Administration Highlights Autism Research Breakthroughs and Prenatal Acetaminophen Risks, Backed by Harvard, Johns Hopkins, and Mount Sinai Studies
President Donald J. Trump joined senior Administration officials to announce significant progress in identifying root causes of autism and to unveil bold new initiatives to confront what has become an alarming public health crisis. Autism spectrum disorder diagnoses have risen dramatically over the past two decades, prompting urgent research into possible contributing factors. Mounting scientific evidence now points to a potential link between acetaminophen use during pregnancy and long-term neurodevelopmental effects in children.
Large-scale cohort studies, including the Nurses’ Health Study II and the Boston Birth Cohort, report associations between in utero exposure to acetaminophen and later diagnoses of autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD). Scientists have outlined biological mechanisms that could plausibly explain how prenatal acetaminophen exposure disrupts fetal brain development and contributes to adverse birth outcomes.
Andrea Baccarelli, M.D., Ph.D., Dean of the Faculty at the Harvard T.H. Chan School of Public Health, underscored these concerns: “Colleagues and I recently conducted a rigorous review, funded by a grant from the National Institutes of Health, of the potential risks of acetaminophen use during pregnancy. We found evidence of an association between exposure to acetaminophen during pregnancy and increased incidence of neurodevelopmental disorders in children.”
Findings from Harvard University, Johns Hopkins University, and Mount Sinai further support these concerns, each identifying elevated risks for autism and ADHD following prenatal use of acetaminophen, also known as Paracetamol or Tylenol.
In 2021, an international consensus statement issued a call for precautionary action, recommending that pregnant women minimize exposure by using the lowest effective dose for the shortest possible time. This advice carries particular weight given that acetaminophen is the most widely used analgesic worldwide and has long been considered the first-line therapy for pain conditions, endorsed by the World Health Organization.
Administration officials emphasized that the Trump Administration does not believe reliance on increasing medication use is always the answer to America’s health challenges. Press Secretary Karoline Leavitt stated, “There is mounting evidence finding a connection between acetaminophen use during pregnancy and autism — and that’s why the Administration is courageously issuing this new health guidance. Additionally, the Trump Administration is approving a new treatment option that has been found to improve some autism symptoms. President Trump pledged to address America’s skyrocketing rates of autism, and his team is deploying Gold Standard Science to deliver on this pledge. We will not be deterred in these efforts as we know millions across America are grateful.”
Date: 26/09/2025
